BET-IN-16 (Comp I), a bromodomain and extra-terminal (BET) inhibitor, demonstrates anticancer activity by impeding the growth of prostate cancer cells. It exhibits potent inhibitory effects with half-maximal inhibitory concentration (IC50) values of 0.043 µM for LNCaP cells and 0.034 µM for 22Rv1 cells [1].
Molecular Weight:
515.56
CAS Number:
[2089390-09-8]
Formula:
C31H25N5O3
Target:
Epigenetic Reader Domain
T78989
* VAT and and shipping costs not included. Errors and price changes excepted